Please assess the completion status of the following clinical trial:

Trial Title: Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male subjects with type 2 diabetes between the age of 20-75 years who can speak and understand Arabic or English~* Female subjects with type 2 diabetes between the age of 20-75 years who can speak and understand Arabic or English~* Patients must be on any basal insulin (once daily)~* Patients must be on any basal insulin (twice daily)~* Patients on stable dose of oral antidiabetes drugs can be included (No change in the dose for the previous 12 weeks)~* Body Mass Index \<40kg/m2~* Subjects who have signed informed consent form~* Patients will be fasting during Ramadan~Exclusion Criteria:~* Type 1 diabetes~* Type 2 diabetes on a basal bolus regimen or those on premix insulin or on self-mix insulin~* On GLP-1 receptor agonists medication~* On glinide medication~* Ischaemic heart disease~* Left bundle branch block on ECG~* Active diabetic retinopathy or maculopathy requiring acute treatment~* Unwilling to follow the protocol~* Pregnancy, intention to become pregnant, breastfeeding

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Insulin glargine U100 (Type: ACTIVE_COMPARATOR): Intervention: half of the subjects will be randomised to insulin glargine U100 basal insulin treatment (or continued on glargine if already treated) that will be administered daily in the evening
- insulin degludec U100 (Type: ACTIVE_COMPARATOR): Intervention: half of the subjects will be randomised to insulin degludec U100 basal insulin treatment that will be administered daily in the evening

Based on this trial design, predict the completion outcome and termination type (if applicable).